Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F5HB
|
|||
Former ID |
DCL000996
|
|||
Drug Name |
Sotrastaurin acetate
|
|||
Synonyms |
Sotrastaurin acetate; UNII-R1SIA15KZ1; 908351-31-5; R1SIA15KZ1; Sotrastaurin acetate [USAN]; AEB 071; Sotrastaurin acetate (USAN); SCHEMBL3846239; CHEMBL2105655; KB-74525; D09718; 3-(1H-Indol-3-yl)-4-(2-(4-methylpiperazin-1-yl)quinazolin-4-yl)-1H-pyrrole-2,5-dione acetate; 1H-Pyrrole-2,5-dione, 3-(1H-indol-3-yl)-4-(2-(4-methyl-1-piperazinyl)-4-quinazolinyl)-, acetate
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Renal transplantation [ICD-11: NE84; ICD-10: D89.8; ICD-9: 279.5] | Phase 2 | [1] | |
Company |
Novartis
|
|||
Structure |
Download2D MOL |
|||
Formula |
C27H26N6O4
|
|||
Canonical SMILES |
CC(=O)O.CN1CCN(CC1)C2=NC3=CC=CC=C3C(=N2)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=C65
|
|||
InChI |
1S/C25H22N6O2.C2H4O2/c1-30-10-12-31(13-11-30)25-27-19-9-5-3-7-16(19)22(28-25)21-20(23(32)29-24(21)33)17-14-26-18-8-4-2-6-15(17)18;1-2(3)4/h2-9,14,26H,10-13H2,1H3,(H,29,32,33);1H3,(H,3,4)
|
|||
InChIKey |
RVEUYBMXVVDLFO-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 908351-31-5
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Emerging drugs for psoriasis. Expert Opin Emerg Drugs. 2009 Mar;14(1):145-63. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.